You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.


The State of Therapeutics in GYN Cancers: Where Are We Headed?

  • Authors: Mansoor Raza Mirza, MD; Bhavana Pothuri, MD, MS; Shannon N. Westin, MD, MPH
  • CME / ABIM MOC Released: 4/7/2022
  • Valid for credit through: 4/7/2023, 11:59 PM EST
Start Activity

Target Audience and Goal Statement

This activity is intended for hematology/oncology specialists, obstetricians & gynecologists, and pathologists.

The goal of this activity is for learners to be better able to collect and disseminate key updates related to gynecologic (GYN) malignancies from the Society of Gynecologic Oncology (SGO) 2022 Annual Meeting on Women’s Cancer through a multisegmented educational initiative.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key clinical trial data for the treatment of GYN malignancies presented in the spring of 2022
    • Implications of emerging data on treatment paradigms for patients with GYN malignancies
  • Demonstrate greater confidence in their ability to
    • Stay abreast of evolving areas of interest for therapies for GYN malignancies


Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


  • Mansoor Raza Mirza, MD

    Department of Oncology 
    Copenhagen University Hospital 
    Copenhagen, Denmark 


    Disclosure: Mansoor Raza Mirza, MD, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Biocad; GlaxoSmithKline; Karyopharm; Merck; Roche; Zailab
    Speaker or member of speakers bureau for: AstraZeneca; GlaxoSmithKline
    Research funding from: Apexigen; AstraZeneca; Deciphera; GlaxoSmithKline; Ultimovacs
    Owns stock (publicly traded) in: Karyopharm
    Other: Member of the Board of Directors: Karyopharm

  • Bhavana Pothuri, MD, MS

    Professor, Department of Obstetrics and Gynecology and Medicine
    NYU School of Medicine
    Perlmutter Cancer Center
    New York, New York, United States


    Disclosure: Bhavana Pothuri, MD, MS, has the following relevant financial relationships:
    Consultant or advisor for: AstraZeneca; Celsion; Clovis Oncology; Eisai; GlaxoSmithKline; Lilly; Merck; Mersana; Onconova; Seagen Inc., formerly Seattle Genetics, Inc.; Sutro; Toray
    Research funding from: AstraZeneca; Celsion; Clovis Oncology; Genetech Roche; GlaxoSmithKline; Karyopharm; Merck; Mersana; Seagen Inc., formerly Seattle Genetics, Inc.; Sutro

  • Shannon N. Westin, MD, MPH

    Associate Professor
    Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
    The University of Texas MD Anderson Cancer
    Houston, Texas, United States


    Disclosure: Shannon N. Weston, MD, MPH, has no relevant financial relationships.


  • Victoria Phoenix, BS

    Medical Education Director, Medscape, LLC


    Disclosure: Victoria Phoenix, BS, has no relevant financial relationships.

Compliance Reviewer

  • Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC


    Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements


Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.


The State of Therapeutics in GYN Cancers: Where Are We Headed?

Authors: Mansoor Raza Mirza, MD; Bhavana Pothuri, MD, MS; Shannon N. Westin, MD, MPHFaculty and Disclosures

CME / ABIM MOC Released: 4/7/2022

Valid for credit through: 4/7/2023, 11:59 PM EST


Contents of This CME Activity

All sections of this activity are required for credit.

Clinical Trial Updates: Endometrial Cancer

Are you up to date on the clinical studies that are examining targetable genes in endometrial cancer?
Mansoor Raza Mirza, MD

Clinical Trial Updates: Ovarian Cancer

Do you know how the results from the SORAYA clinical trial will change how your treat some of your ovarian cancer patients?
Bhavana Pothuri, MD, MS

Clinical Trial Updates: Cervical Cancer

Did you know that changes are coming in front-line therapy for cervical cancer?
Shannon N. Westin, MD, MPH

Assessment Survey

Before you begin, please take this brief survey.

  • Print